Search
In this February 24, 2022 editorial published on the Connecticut Business & Industry Association’s website, Paul Pescatello reviews the practical reasons that mean that importing drugs from Canada will not lower prescription drug prices. Pescatello is the executive director of CBIA’s Bioscience Growth Council and chair of We Work for Health Connecticut.
Read More
Washington, D.C. (August 12, 2021) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Synthetic Opioid Trafficking Commission’s Final Report
Read More
The Commission on Combating Synthetic Opioid Trafficking’s Final Report makes recommendations for a complex, multipronged federal response to the fentanyl crisis.
Read More
The Office of the US Trade Representative released this year’s Review of Notorious Markets, which identifies markets that “engage in, facilitate, turn a blind eye to, or benefit from substantial piracy or counterfeiting.”
Click through to see this report, and catch up on more than 30 stories about counterfeit medicine.
Read More